A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout

Annals of the Rheumatic Diseases

Volumn 67, Issue 6, 2008, Pages 888-891

  Taylor, William J ^a,z   Schumacher Jr , H R ^b   Baraf, H S B ^c   Chapman, P ^d   Stamp, L ^e   Doherty, M ^f   McQueen, F ^g   Dalbeth, N ^g   Schlesinger, N ^h   Furst, D E ⁱ   Vazquez Mellado, J ^j   Becker, M A ^k   Kavanaugh, A ^l   Louthrenoo, W ^m   Bardin, T ⁿ   Khanna, D ⁱ   Simon, L S ^o   Yamanaka, H ^p   Choi, H K ^q   Zeng, X ^r   Strand, V ^s   Grainger, R ^a   Clegg, D ^t   Singh, J A ^u   Diaz Torne, C ^v   Boers, M ^w   Gow, P ^x   Barskova, V G ^y   more..

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

^h ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j HOSPITAL GENERAL DE MÉXICO   (Mexico)

^k UNIVERSITY OF CHICAGO   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m CHIANG MAI UNIVERSITY   (Thailand)

ⁿ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^o HARVARD MEDICAL SCHOOL   (United States)

^p TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^q UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^r PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^s STANFORD UNIVERSITY   (United States)

^t UNIVERSITY OF UTAH   (United States)

^u UNIVERSITY OF MINNESOTA   (United States)

^v HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^w VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^x Division of Medicine Emergency and Integrated Care   (New Zealand)

^y V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^z UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTHRITIS; ARTICLE; CHRONIC DISEASE; CONSENSUS; DELPHI STUDY; GOUT; HUMAN; MUSCULOSKELETAL FUNCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE;

ACUTE DISEASE; CHRONIC DISEASE; CONSENSUS; DELPHI TECHNIQUE; GOUT; HEALTH STATUS INDICATORS; HUMANS; RHEUMATOLOGY; TREATMENT OUTCOME;

EID: 45149130372     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.079970     Document Type: Article

References (16)

1. Schumacher HR Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002;324:1488-92.
2. Willburger RE, Mysler E, Derbot J, Jung T, Thurston H, Kreiss A, et al. Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. Rheumatology (Oxford) 2007;46:1126-32.
3. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-61.
4. Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland L, Huang B, et al. A Phase 2 study of multiple doses of intravenous polyethylene glycol (PEG)-uricase in patients with hyperuricemia and refractory gout. Arthritis Rheum 2005;52(Suppl 9):S679-80.
5. Schumacher HR Jr, Edwards LN, Perez, Ruiz F, Becker M, Chen LX, et al. Outcome measures for acute and chronic gout. J Rheumatol 2005;32:2452-5.
6. Schumacher HR, Taylor W, Joseph Ridge N, Perez Ruiz F, Chen LX, Schlesinger N, et al. Outcome evaluations in gout. J Rheumatol 2007;34:1381-5.
7. Graham B, Regehr G, Wright JG. Delphi as a method to establish consensus for diagnostic criteria. J Clin Epidemiol 2003;56:1150- 6.
8. Grainger R, Harrison AA, Taylor WJ. Preliminary identification of potentials items for a definition of "gout flare" using Delphi methodology. Arthritis Rheum 2005;52(Suppl. 9):S105.
9. Taylor WJ, Schumacher Jr HR, Singh JA, Grainger R, Dalbeth N. Assessment of outcome in clinical trials of gout - a review of current measures. Rheumatology (Oxford) 2007;46:1751-6.
10. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RANDI UCLA Appropriateness Method User's Manual. Santa Monica, CA: RAND, 2001.
11. Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70.
12. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P, et al. Endpoints: consensus recommendations from OMERACT IV. Lupus 2000;9:322-7.
13. Sambrook PN, Cummings SR, Eisman JA, Genant HK, Eastell R, Reginster JY, et al. Guidelines for osteoporosis trials. J Rheumatol 1997;24:1234-6.
14. Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 1997;24:799-802.
15. Cieza A, Ewert T, Ustun TB, Chatterjee S, Kostanjsek N, Stucki G. Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med 2004;Suppl. 44:9-11.
16. Boers M, Brooks P, Strand V, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.